2.50BMarket Cap
14.31P/E TTM
Key Figures
72.380Open
73.860High
1.14MVolume
14.31P/E TTM
22.61P/E Dynamic
--Dividend TTM
3.30%Turnover Ratio
71.130Prev. Close
68.800Low
63.88MTurnover
70.39P/E Static
5.05P/B
0.00%Div Yield TTM
15.13%ROA
156.00052wk High
1.27Volume Ratio
35.46MNet Profit
34.55MShares
5.0490EPS TTM
1.94Beta
45.22%ROE
60.10552wk Low
7.11%Amplitude
58.16%Gross Margin
2.50BMarket Cap
1.26Reward/Risk
3.12%Risk Rate
Currency: USD Updated: 2026-07-24 Key Insights
Transmedics Group Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 15 out of 200 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 119.56.In the medium term, the stock price is expected to trend down.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Transmedics Group Inc's Score
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Transmedics Group Inc Highlights
StrengthsRisks
Transmedics Group Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Transmedics Group Inc
TMDX
12
Intuitive Surgical Inc
ISRG
35
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Indicators
Financial Indicators
EPS

Relevant data have not been disclosed by the company yet.
Total revenue

Relevant data have not been disclosed by the company yet.
Transmedics Group Inc Info
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Ticker SymbolTMDX
CompanyTransmedics Group Inc
CEOHassanein (Waleed H)
Websitehttps://www.transmedics.com/
Shareholders
FAQs
What is the current price of Transmedics Group Inc (TMDX)?
The current price of Transmedics Group Inc (TMDX) is 72.26.
What is the symbol of Transmedics Group Inc?
The ticker symbol of Transmedics Group Inc is TMDX.
What is the 52-week high of Transmedics Group Inc?
The 52-week high of Transmedics Group Inc is 156.00.
What is the 52-week low of Transmedics Group Inc?
The 52-week low of Transmedics Group Inc is 60.10.
What is the market capitalization of Transmedics Group Inc?
The market capitalization of Transmedics Group Inc is 2.50B.
Is Transmedics Group Inc (TMDX) currently rated as Buy, Hold, or Sell?
According to analysts, Transmedics Group Inc (TMDX) has an overall rating of Buy, with a price target of 118.44.
What is the Earnings Per Share (EPS TTM) of Transmedics Group Inc (TMDX)?
The Earnings Per Share (EPS TTM) of Transmedics Group Inc (TMDX) is 5.60.